Pengaruh Return on Assets (ROA) dan Debt to Equity Ratio (DER) Terhadap Harga Saham Pada PT. Mayora Indah TBK Periode 2011-2020
Formosa Journal of Sustainable Research · 2022
DOI: 10.55927/fjsr.v1i2.753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Formosa Journal of Sustainable Research, 2022. Verfasst von Syifa Fauziah und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This research was conducted at PT. Mayora Indah, Tbk for the period 2011-2020 aims to examine the effect of return on assets and debt to equity ratio on stock prices. The independent variables are return on assets and debt to equity ratio. The dependent variable is the stock price. This type of research is quantitative with the help of SPSS version 26, the type of secondary data. The test uses classical assumption test, simple linear regression analysis, multiple linear regression analysis, hypothesis testing, and determination test. The results show that partially the return on assets has no effect on stock prices and the debt-to-equity ratio partially affects stock prices. And based on the F test return on assets and debt to equity ratio simultaneously affect stock prices
Zitieren
APA
Fauziah, S., & Priyanto, A. A. (2022). Pengaruh Return on Assets (ROA) dan Debt to Equity Ratio (DER) Terhadap Harga Saham Pada PT. Mayora Indah TBK Periode 2011-2020. Formosa Journal of Sustainable Research. https://doi.org/10.55927/fjsr.v1i2.753
Vancouver
Fauziah S, Priyanto AA. Pengaruh Return on Assets (ROA) dan Debt to Equity Ratio (DER) Terhadap Harga Saham Pada PT. Mayora Indah TBK Periode 2011-2020. Formosa Journal of Sustainable Research. 2022. doi:10.55927/fjsr.v1i2.753
BibTeX
@article{Fauziah2022,
author = {Fauziah, Syifa and Priyanto, Aria Aji},
title = {Pengaruh Return on Assets (ROA) dan Debt to Equity Ratio (DER) Terhadap Harga Saham Pada PT. Mayora Indah TBK Periode 2011-2020},
journal = {Formosa Journal of Sustainable Research},
year = {2022},
doi = {10.55927/fjsr.v1i2.753}
}
EUVIMED